120.65
-0.035(-0.03%)
Currency In USD
| Previous Close | 120.68 |
| Open | 121.25 |
| Day High | 122.21 |
| Day Low | 120.49 |
| 52-Week High | 249.91 |
| 52-Week Low | 108.9 |
| Volume | 232,836 |
| Average Volume | 558,193.9 |
| Market Cap | 5.33B |
| PE | 28.19 |
| EPS | 4.28 |
| Moving Average 50 Days | 118.07 |
| Moving Average 200 Days | 150.18 |
| Change | -0.04 |
If you invested $1000 in Teleflex Incorporated (TFX) 10 years ago, it would be worth $940.56 as of August 18, 2025 at a share price of $120.645. Whereas If you bought $1000 worth of Teleflex Incorporated (TFX) shares 5 years ago, it would be worth $329.81 as of August 18, 2025 at a share price of $120.645.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
GlobeNewswire Inc.
Jul 17, 2025 10:30 AM GMT
WAYNE, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 31, 2025. To pa
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
GlobeNewswire Inc.
Jul 01, 2025 10:30 AM GMT
WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Inter
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewswire Inc.
Jun 12, 2025 10:30 AM GMT
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Centr